These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 2910463)
1. Conversion to the terminally differentiated state during treatment of NG108-15 neural tumor cells with 1-beta-D-arabinofuranosylcytosine in defined medium. Krystosek A Cancer Res; 1989 Jan; 49(2):450-8. PubMed ID: 2910463 [TBL] [Abstract][Full Text] [Related]
2. Neurite formation by neuroblastoma-glioma hybrid cells (NG108-15) in defined medium: stochastic initiation with persistence of differentiated functions. Krystosek A J Cell Physiol; 1985 Nov; 125(2):319-29. PubMed ID: 2997240 [TBL] [Abstract][Full Text] [Related]
3. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67). Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670 [TBL] [Abstract][Full Text] [Related]
4. Ara-C treatment leads to differentiation and reverses the transformed phenotype in a human rhabdomyosarcoma cell line. Crouch GD; Kalebic T; Tsokos M; Helman LJ Exp Cell Res; 1993 Feb; 204(2):210-6. PubMed ID: 8440318 [TBL] [Abstract][Full Text] [Related]
5. Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity. Vadi H; Drewinko B Cancer Res; 1986 Mar; 46(3):1105-9. PubMed ID: 3080232 [TBL] [Abstract][Full Text] [Related]
6. Selective destruction of cultured tumor cells with uncontrolled nuclear division by cytochalasin B and cytosine arabinoside. O'Neill FJ Cancer Res; 1975 Nov; 35(11 Pt 1):3111-5. PubMed ID: 1182703 [TBL] [Abstract][Full Text] [Related]
7. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers. Chen YL; Wu RT Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611 [TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine. Bhalla K; Nayak R; Grant S Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869 [TBL] [Abstract][Full Text] [Related]
9. Characterization of tumor cell heterogeneity of a murine leukemia cell line (L1210) in response to arabinosylcytosine: quantitation using a computerized image analysis system. Raymakers RA; Slocum HK; Minderman H; Malmberg M; Rustum YM Exp Hematol; 1993 May; 21(5):602-7. PubMed ID: 8513859 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of cell-killing effects of 1-beta-D-arabinofuranosylcytosine and daunorubicin by a new computer-controlled in vitro pharmacokinetic simulation system. Kishi S; Goto N; Nakamura T; Ueda T Cancer Res; 1999 Jun; 59(11):2629-34. PubMed ID: 10363985 [TBL] [Abstract][Full Text] [Related]
11. Potential for selective enhancement of the in vivo metabolism of 1-beta-D-arabinofuranosylcytosine in rats by thymidine pretreatment. Danhauser LL; Rustum YM Cancer Res; 1985 May; 45(5):2002-7. PubMed ID: 3986756 [TBL] [Abstract][Full Text] [Related]
12. Effect of cytosine arabinoside on the growth and phenotypic expression of GI-ME-N, a new human neuroblastoma cell line. Ponzoni M; Melodia A; Cirillo C; Casalaro A; Cornaglia-Ferraris P Prog Clin Biol Res; 1988; 271():437-48. PubMed ID: 3406012 [TBL] [Abstract][Full Text] [Related]
14. Direct relationship of marrow cell growth and 1-beta-D-arabinofuranosylcytosine metabolism. Karp JE; Donehower RC; Dole GB; Burke PJ Cancer Res; 1984 Nov; 44(11):5046-50. PubMed ID: 6488163 [TBL] [Abstract][Full Text] [Related]
15. Terminal erythroid differentiation in the K-562 cell line by 1-beta-D-arabinofuranosylcytosine: accompaniment by c-myc messenger RNA decrease. Bianchi Scarrà GL; Romani M; Coviello DA; Garrè C; Ravazzolo R; Vidali G; Ajmar F Cancer Res; 1986 Dec; 46(12 Pt 1):6327-32. PubMed ID: 3536078 [TBL] [Abstract][Full Text] [Related]
16. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation. Ferrero D; Tarella C; Gallo E; Ruscetti FW; Breitman TR Cancer Res; 1982 Nov; 42(11):4421-6. PubMed ID: 6957259 [TBL] [Abstract][Full Text] [Related]
17. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation. Law PY; Bergsbaken C J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347 [TBL] [Abstract][Full Text] [Related]
18. BMP-6 and retinoic acid synergistically differentiate the IMR-32 human neuroblastoma cells. Sumantran VN; Brederlau A; Funa K Anticancer Res; 2003; 23(2B):1297-303. PubMed ID: 12820386 [TBL] [Abstract][Full Text] [Related]
19. Ni-coupled receptors in cultured neural hybrid cells: cell specificity for dibutyryl cyclic AMP-induced down-regulation but not morphological differentiation. Noronha-Blob L; Lowe VC; Kinnier WJ; U'Prichard DC Mol Pharmacol; 1986 Dec; 30(6):526-36. PubMed ID: 3023808 [TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of the cytokinetic response of KHT tumors in vivo to 1-beta-D-arabinofuranosylcytosine. Pallavicini MG; Gray JW; Folstad LJ Cancer Res; 1982 Aug; 42(8):3125-31. PubMed ID: 7093956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]